The Maha Commission Strategy report calls for an end to overmedicalization of our children. Unnecessary medical interventions drive big money interests that push sex rejecting treatments. Today's revenue for sex rejecting drugs and surgeries in 2023 were estimated in one study to exceed $4.4 billion and on track to exceed 7.8 billion by 2030. One doctor was recorded callously describing sex rejecting procedures as a big moneymaker. Hospitals rake in millions of dollars by convincing poison girls and a lifetime of off label prescriptions … (06:52–07:09)
CLAIM
Asserts that the market for sex rejecting drugs and surgeries is projected to grow significantly.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
